Kenvue Inc. (KVUE) est une société cotée en bourse dans le Consommation Défensive secteur, opérant dans le Household & Personal Products secteur d'activité. Le siège social de l'entreprise est situé à Summit, NJ, United States. Le PDG actuel est Kirk L. Perry.
KVUE a date d'introduction en bourse 2023-05-04, 22,000 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $33.31B.
Kenvue Inc. is a global consumer health company offering a diverse portfolio of over-the-counter medications and personal care products across three main segments. The Self Care segment includes pain relief, cold and allergy remedies, digestive health, and smoking cessation products marketed under brands such as Tylenol, Zyrtec, and Nicorette. The Skin Health and Beauty segment provides facial, body, and hair care products under the Neutrogena, Aveeno, and OGX brands, while the Essential Health segment offers oral care, baby care, women's health, and wound care solutions through brands including Listerine, Johnson's, Band-Aid, and Stayfree. Incorporated in 2022 and headquartered in Skillman, New Jersey, Kenvue operates as a subsidiary of Johnson & Johnson.
